Preimplantation genetic screening (PGS) in infertile female age ≥ 35 years by fluorescence in situ hybridization of chromosome 13, 18, 21, X and Y

Journal of the Medical Association of Thailand

Volumn 91, Issue 11, 2008, Pages 1644-1650

  Chiamchanya, Charoenchai ^a   Visutakul, Pachara ^a   Gumnarai, Nuntana ^b   Su angkawatin, Wanasaya ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

Author keywords

Assisted reproductive technology (ART); Chromosomal aneuploidy; Male partner age; Maternal age; Preimplantation genetic screening (PGS)

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SCREENING; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MALE; PRENATAL DIAGNOSIS; X CHROMOSOME; Y CHROMOSOME;

ABORTION, INDUCED; ADULT; AGE FACTORS; ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; INFERTILITY, FEMALE; MALE; MATERNAL AGE; MIDDLE AGED; PREGNANCY; PREGNANCY RATE; PREIMPLANTATION DIAGNOSIS; PROSPECTIVE STUDIES; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 57149098813     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983; 249: 2034-8.
2. Verlinsky Y, Kuliev AM. Preimplantation diagnosis of genetic diseases: a new technique in assisted reproduction. New York: Wiley-Liss; 1993.
3. Penketh R, McLaren A. Prospects for prenatal diagnosis during preimplantation human development. Baillieres Clin Obstet Gynaecol 1987; 1: 747-64.
4. Handyside A. Prospects for the clinical application of preimplantation diagnosis: the tortoise or the hare? Hum Reprod 1992; 7: 1481-3.
5. nd ed. London: Martin Dunitz; 2004: 355-77.
6. Cohen J, Wells D, Munne S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril 2007; 87: 496-503.
7. Abdelhadi I, Colls P, Sandalinas M, Escudero T, Munne S. Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes. Reprod Biomed Online 2003; 6: 226-31.
8. Munne S, Chen S, Colls P, Garrisi J, Zheng X, Cekleniak N, et al. Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online 2007; 14: 628-34.
9. Parikh FR, Madon PF, Athalye AS, Naik NJ, Gada SD, Ganla KN, et al. Preimplantation genetic diagnosis of chromosomal abnormalities by multicolour fluorescence in situ hybridisation. J Indian Med Assoc 2001; 99: 441-4.
10. Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995; 10: 356-67.
11. Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111: 777-84.
12. th ed. New York: McGraw-Hill; 2005: 285-312.
13. rd ed. Baltimore: The Johns Hopkins University Press, 1993: 1-32.